revitope.com

Revitope

Revitope's email is info@revitope.com .

Revitope is developing a novel approach to cancer immunotherapy. Cancer patients typically have strong cytotoxic immunity against viral pathogens while lacking immunity against their tumors. Revitope’s technology redirects an exisiting viral immune response to treat cancer. Revitope’s antibody peptide epitope complex (APEC) technology selectively delivers an immunodominant viral peptide to the tumor cell, thereby activating exisiting T cells that recognize the tumor as virally infected, and kill it.
View Top Employees for Revitope
img Website revitope.com
img Industry Biotechnology
img Location Cambridge, Massachusetts, United States
img Employees 20
img Founded 2016
img HQ 953 Indiana Street
img Email info@revitope.com
img Funding 8,500,000 USD
img Competitors Roche, Agilent Technologies, Amgen, Genentech, Eurofins, Gilead Sciences,
img Website revitope.com
img Industry Biotechnology
img Location Cambridge, Massachusetts, United States
img Employees 20
img Founded 2016
img LinkedIn linkedin.com/company/revitope
img HQ 953 Indiana Street
img Email info@revitope.com
img Funding 8,500,000 USD

Top Revitope Employees